These are top 10 stocks traded on the Robinhood UK platform in July
Tuesday, Truist Securities adjusted its outlook on Curtiss-Wright (NYSE:CW), increasing the price target to $356 from the previous $338 while maintaining a Hold rating on the company’s shares. Currently trading at $387.37 and near its 52-week high of $393.40, the stock has shown remarkable strength with a 42% return over the past year. The revision follows Curtiss-Wright’s first-quarter performance in 2025, which surpassed expectations in both revenue and earnings per share (EPS). According to InvestingPro, seven analysts have recently revised their earnings estimates upward for the upcoming period.
The company not only reported strong quarterly results but also raised its outlook for the entirety of 2025. With revenue reaching $3.21 billion and maintaining a GREAT financial health score according to InvestingPro, Curtiss-Wright demonstrates solid operational performance. A key highlight from the first quarter was the robust orders, which reflected a book-to-bill ratio of 1.26 times. Truist Securities noted that despite facing tariff-related headwinds, Curtiss-Wright has been successful in mitigating these through strategic pricing and operational actions. Additionally, the firm’s restructuring efforts have seen modest expansion, contributing to its impressive 9.77% revenue growth.
A significant area of growth for Curtiss-Wright has been its commercial nuclear revenues, which have seen an organic high single-digit (HSD) growth rate in the first quarter of 2025. This trend is expected to continue throughout the year, driven by a combination of aftermarket demand and Small Modular Reactor (SMR) demand. In light of these developments, Truist Securities has elevated its estimates for Curtiss-Wright for the years 2025 and 2026.
The analyst from Truist Securities commented on the company’s performance and outlook, stating: "Solid Performance in 1Q25; We maintain our HOLD rating and raise our PT to $356 (from $338) on CW post 1Q25. 1Q25 results beat on revenue and EPS and mgmt raised their 2025 outlook. Orders in the quarter were strong with a 1.26x B2B, tariff headwinds are being mitigated through pricing and operational actions, and restructuring efforts have modestly expanded. Commercial nuclear revenues expanded at a HSD rate organically in 1Q25 and should hold that rate for the balance of the year on a combo of aftermarket and SMR demand. We have increased our ests for 25/26 but remain somewhat cautious on the pace of the nuclear SMR ramp."
Despite the positive developments and increased estimates, the Hold rating suggests a level of caution from Truist Securities regarding the pace at which the nuclear SMR segment is expected to grow. This conservative stance is reflected in the decision to maintain the current rating while acknowledging the company’s solid quarterly performance and improved financial outlook. Trading at a P/E ratio of 34.24x, InvestingPro analysis suggests the stock is currently overvalued, with 14 additional ProTips available to subscribers looking to dive deeper into Curtiss-Wright’s valuation and growth prospects.
In other recent news, Curtiss-Wright Corporation reported impressive financial results for the first quarter of 2025, surpassing analyst expectations. The company achieved an earnings per share (EPS) of $2.82, significantly exceeding the forecasted $2.43. Revenue also outperformed projections, reaching $860 million against the anticipated $764.19 million. This strong performance led Curtiss-Wright to raise its full-year sales and EPS guidance, reflecting confidence in continued market strength and operational improvements.
Additionally, the company demonstrated robust year-over-year growth, with sales increasing by 13% and operating income rising by 34%. Curtiss-Wright’s operating margin expanded by 260 basis points, driven by strong demand in defense and commercial markets. The company’s strategic investments in technology and innovation contributed to these results. Furthermore, Curtiss-Wright’s new orders increased by 13%, surpassing $1 billion, highlighting the company’s successful execution of its strategic initiatives.
Curtiss-Wright is also addressing potential challenges, such as tariffs and supply chain disruptions, which could impact costs and margins. Despite these challenges, the company remains optimistic, with analysts from firms like Alembic Global and Morgan Stanley (NYSE:MS) showing interest in Curtiss-Wright’s strategies and market opportunities. Overall, these developments indicate a positive outlook for Curtiss-Wright in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.